All In MedTech

Device Trial Radar · NCT05329246

Validation of PMcardio AI-assisted Clinical Assistant in Primary Care

Validation of AI-assisted Clinical Assistant for Effective Management of Cardiovascular Diseases in Primary Health Care: PMcardio-1 Trial

Last checked: Nov 20, 2026Latest source record: Aug 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 836 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

836

Actual

Start

Nov 22, 2021

Primary completion

Jun 30, 2022

Study completion Jun 30, 2022

Sponsor

Lead sponsor
Powerful MedicalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 14, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aimed to analyze and investigate whether the use of the PMcardio clinical assistant leads to a more efficient patient management in primary care and more accessible specialised care compared to usual standards of care and to assess the reliability and safety of the PMcardio smartphone application in the primary care use environment. Additionally, to evaluate time savings and cost saving implications of increased availability of specialised care at the primary care level.

Conditions

  • Cardiovascular Diseases
  • Medical Device
  • Primary Health Care
  • Electrocardiogram
  • Dyspnea
  • Chest Pain
  • Syncope
  • Breath Shortness
  • General Practitioner

Interventions

  • AI-assisted Clinical Assistant PMcardioDevice

    PMcardio is an AI-powered clinical assistant in the form of a mobile application empowering non-cardiologist healthcare workers with advanced cardiovascular diagnostic capabilities, recommending patient-specific suggestions for referral and facilitating remote consultations with specialized cardiologists.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to first cardiovascular-related consultationTime frame: From randomization to enrollment period completion (up to 6 months)

3 more outcomes with a free account

Locations

56 sites in 1 country. Site status is shown where the registry gives one.

  • MUZMED s.r.o.

    Bardejov, Slovakia

55 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.